COM:IMAGOBIO

Imago BioSciences, Inc.

Stock

Last Close

36.01

10/01 21:00

Volume Today

138.13K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21
net income	-10.90M -	-17.83M 63.58%	-42.31M 137.26%
depreciation and amortization		1K -	6K 500%
deferred income tax
stock based compensation	318K -	426K 33.96%	2.23M 422.30%
change in working capital	271K -	672K 147.97%	208K 69.05%
accounts receivables
inventory
accounts payables	586K -	8K 98.63%	2.06M 25,675%
other working capital	-315K -	664K 310.79%	-1.85M 379.22%
other non cash items	305K -	-208K 168.20%	109K 152.40%
net cash provided by operating activities	-10.01M -	-16.94M 69.28%	-39.76M 134.70%
investments in property plant and equipment		-9K -
acquisitions net
purchases of investments	-2.73M -	-81.08M 2,872.25%	-208.42M 157.05%
sales maturities of investments		6.75M -	79.15M 1,072.64%
other investing activites
net cash used for investing activites	-2.73M -	-74.34M 2,625.15%	-129.27M 73.88%
debt repayment
common stock issued			163.74M -
common stock repurchased
dividends paid
other financing activites	16.44M -	105.59M 542.31%	-2.75M 102.60%
net cash used provided by financing activities	16.44M -	105.59M 542.31%	160.99M 52.47%
effect of forex changes on cash
net change in cash	3.70M -	14.30M 286.31%	-8.04M 156.20%
cash at beginning of period	1.26M -	4.96M 294.36%	19.27M 288.35%
cash at end of period	4.96M -	19.27M 288.35%	11.23M 41.73%
operating cash flow	-10.01M -	-16.94M 69.28%	-39.76M 134.70%
capital expenditure		-9K -
free cash flow	-10.01M -	-16.95M 69.37%	-39.76M 134.58%

All numbers in (except ratios and percentages)